Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical ...
Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 ...
17h
TG Therapeutics, Inc.: TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
Phase 3 trial met its primary endpoint, demonstrating bioequivalent drug exposure between the currently approved BRIUMVI Day 1 and Day 15 initiation dosing and a new single infusion on Day 1 only Safe ...
ORLANDO, Fla. — The Florida Department of Health held its first public workshop Friday on the subject of changing state rules regarding vaccines. It’s part of an ongoing push led by the state’s ...
Researchers have discovered how acids on the surface of bacteria give these microscopic organisms their characteristic "rod" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results